ReviewPharmaceutics2022

Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?

Eva Choong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.